Skip to main content
Top
Published in: Critical Care 5/2010

Open Access 01-10-2010 | Research

Effects of hydrogen sulfide on hemodynamics, inflammatory response and oxidative stress during resuscitated hemorrhagic shock in rats

Authors: Frédérique Ganster, Mélanie Burban, Mathilde de la Bourdonnaye, Lionel Fizanne, Olivier Douay, Laurent Loufrani, Alain Mercat, Paul Calès, Peter Radermacher, Daniel Henrion, Pierre Asfar, Ferhat Meziani

Published in: Critical Care | Issue 5/2010

Login to get access

Abstract

Introduction

Hydrogen sulfide (H2S) has been shown to improve survival in rodent models of lethal hemorrhage. Conversely, other authors have reported that inhibition of endogenous H2S production improves hemodynamics and reduces organ injury after hemorrhagic shock. Since all of these data originate from unresuscitated models and/or the use of a pre-treatment design, we therefore tested the hypothesis that the H2S donor, sodium hydrosulfide (NaHS), may improve hemodynamics in resuscitated hemorrhagic shock and attenuate oxidative and nitrosative stresses.

Methods

Thirty-two rats were mechanically ventilated and instrumented to measure mean arterial pressure (MAP) and carotid blood flow (CBF). Animals were bled during 60 minutes in order to maintain MAP at 40 ± 2 mm Hg. Ten minutes prior to retransfusion of shed blood, rats randomly received either an intravenous bolus of NaHS (0.2 mg/kg) or vehicle (0.9% NaCl). At the end of the experiment (T = 300 minutes), blood, aorta and heart were harvested for Western blot (inductible Nitric Oxyde Synthase (iNOS), Nuclear factor-κB (NF-κB), phosphorylated Inhibitor κB (P-IκB), Inter-Cellular Adhesion Molecule (I-CAM), Heme oxygenase 1(HO-1), Heme oxygenase 2(HO-2), as well as nuclear respiratory factor 2 (Nrf2)). Nitric oxide (NO) and superoxide anion (O2-) were also measured by electron paramagnetic resonance.

Results

At the end of the experiment, control rats exhibited a decrease in MAP which was attenuated by NaHS (65 ± 32 versus 101 ± 17 mmHg, P < 0.05). CBF was better maintained in NaHS-treated rats (1.9 ± 1.6 versus 4.4 ± 1.9 ml/minute P < 0.05). NaHS significantly limited shock-induced metabolic acidosis. NaHS also prevented iNOS expression and NO production in the heart and aorta while significantly reducing NF-kB, P-IκB and I-CAM in the aorta. Compared to the control group, NaHS significantly increased Nrf2, HO-1 and HO-2 and limited O2- release in both aorta and heart (P < 0.05).

Conclusions

NaHS is protective against the effects of ischemia reperfusion induced by controlled hemorrhage in rats. NaHS also improves hemodynamics in the early resuscitation phase after hemorrhagic shock, most likely as a result of attenuated oxidative stress. The use of NaHS hence appears promising in limiting the consequences of ischemia reperfusion (IR).
Appendix
Available only for authorised users
Literature
1.
go back to reference Kauvar DS, Lefering R, Wade CE: Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma. 2006, 60: S3-11. 10.1097/01.ta.0000199961.02677.19.CrossRefPubMed Kauvar DS, Lefering R, Wade CE: Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma. 2006, 60: S3-11. 10.1097/01.ta.0000199961.02677.19.CrossRefPubMed
2.
go back to reference Sauaia A, Moore FA, Moore EE, Moser KS, Brennan R, Read RA, Pons PT: Epidemiology of trauma deaths: a reassessment. J Trauma. 1995, 38: 185-193. 10.1097/00005373-199502000-00006.CrossRefPubMed Sauaia A, Moore FA, Moore EE, Moser KS, Brennan R, Read RA, Pons PT: Epidemiology of trauma deaths: a reassessment. J Trauma. 1995, 38: 185-193. 10.1097/00005373-199502000-00006.CrossRefPubMed
3.
go back to reference Rushing GD, Britt LD: Reperfusion injury after hemorrhage: a collective review. Ann Surg. 2008, 247: 929-937. 10.1097/SLA.0b013e31816757f7.CrossRefPubMed Rushing GD, Britt LD: Reperfusion injury after hemorrhage: a collective review. Ann Surg. 2008, 247: 929-937. 10.1097/SLA.0b013e31816757f7.CrossRefPubMed
4.
go back to reference Landry DW, Oliver JA: The pathogenesis of vasodilatory shock. N Engl J Med. 2001, 345: 588-595. 10.1056/NEJMra002709.CrossRefPubMed Landry DW, Oliver JA: The pathogenesis of vasodilatory shock. N Engl J Med. 2001, 345: 588-595. 10.1056/NEJMra002709.CrossRefPubMed
5.
go back to reference Collard CD, Gelman S: Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. Anesthesiology. 2001, 94: 1133-1138. 10.1097/00000542-200106000-00030.CrossRefPubMed Collard CD, Gelman S: Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. Anesthesiology. 2001, 94: 1133-1138. 10.1097/00000542-200106000-00030.CrossRefPubMed
6.
go back to reference Couch L, Martin L, Rankin N: Near death episode after exposure to toxic gases from liquid manure. N Z Med J. 2005, 118: U1414-PubMed Couch L, Martin L, Rankin N: Near death episode after exposure to toxic gases from liquid manure. N Z Med J. 2005, 118: U1414-PubMed
7.
go back to reference Wang R: Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter?. FASEB J. 2002, 16: 1792-1798. 10.1096/fj.02-0211hyp.CrossRefPubMed Wang R: Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter?. FASEB J. 2002, 16: 1792-1798. 10.1096/fj.02-0211hyp.CrossRefPubMed
8.
go back to reference Lowicka E, Beltowski J: Hydrogen sulfide (H2S) - the third gas of interest for pharmacologists. Pharmacol Rep. 2007, 59: 4-24.PubMed Lowicka E, Beltowski J: Hydrogen sulfide (H2S) - the third gas of interest for pharmacologists. Pharmacol Rep. 2007, 59: 4-24.PubMed
9.
go back to reference Wagner F, Asfar P, Calzia E, Radermacher P, Szabo C: Bench-to-bedside review: Hydrogen sulfide - the third gaseous transmitter: applications for critical care. Crit Care. 2009, 13: 213-10.1186/cc7700.PubMedCentralCrossRefPubMed Wagner F, Asfar P, Calzia E, Radermacher P, Szabo C: Bench-to-bedside review: Hydrogen sulfide - the third gaseous transmitter: applications for critical care. Crit Care. 2009, 13: 213-10.1186/cc7700.PubMedCentralCrossRefPubMed
10.
go back to reference Blackstone E, Morrison M, Roth MB: H2S induces a suspended animation-like state in mice. Science. 2005, 308: 518-10.1126/science.1108581.CrossRefPubMed Blackstone E, Morrison M, Roth MB: H2S induces a suspended animation-like state in mice. Science. 2005, 308: 518-10.1126/science.1108581.CrossRefPubMed
11.
go back to reference Blackstone E, Roth MB: Suspended animation-like state protects mice from lethal hypoxia. Shock. 2007, 27: 370-372. 10.1097/SHK.0b013e31802e27a0.CrossRefPubMed Blackstone E, Roth MB: Suspended animation-like state protects mice from lethal hypoxia. Shock. 2007, 27: 370-372. 10.1097/SHK.0b013e31802e27a0.CrossRefPubMed
12.
go back to reference Szabo C: Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov. 2007, 6: 917-935. 10.1038/nrd2425.CrossRefPubMed Szabo C: Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov. 2007, 6: 917-935. 10.1038/nrd2425.CrossRefPubMed
13.
go back to reference Zhang H, Zhi L, Moore PK, Bhatia M: Role of hydrogen sulfide in cecal ligation and puncture-induced sepsis in the mouse. Am J Physiol Lung Cell Mol Physiol. 2006, 290: L1193-L1201. 10.1152/ajplung.00489.2005.CrossRefPubMed Zhang H, Zhi L, Moore PK, Bhatia M: Role of hydrogen sulfide in cecal ligation and puncture-induced sepsis in the mouse. Am J Physiol Lung Cell Mol Physiol. 2006, 290: L1193-L1201. 10.1152/ajplung.00489.2005.CrossRefPubMed
14.
go back to reference Kubo S, Kurokawa Y, Doe I, Masuko T, Sekiguchi F, Kawabata A: Hydrogen sulfide inhibits activity of three isoforms of recombinant nitric oxide synthase. Toxicology. 2007, 241: 92-97. 10.1016/j.tox.2007.08.087.CrossRefPubMed Kubo S, Kurokawa Y, Doe I, Masuko T, Sekiguchi F, Kawabata A: Hydrogen sulfide inhibits activity of three isoforms of recombinant nitric oxide synthase. Toxicology. 2007, 241: 92-97. 10.1016/j.tox.2007.08.087.CrossRefPubMed
15.
go back to reference Ali MY, Ping CY, Mok YY, Ling L, Whiteman M, Bhatia M, Moore PK: Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide?. Br J Pharmacol. 2006, 149: 625-634. 10.1038/sj.bjp.0706906.PubMedCentralCrossRefPubMed Ali MY, Ping CY, Mok YY, Ling L, Whiteman M, Bhatia M, Moore PK: Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide?. Br J Pharmacol. 2006, 149: 625-634. 10.1038/sj.bjp.0706906.PubMedCentralCrossRefPubMed
16.
go back to reference Morrison ML, Blackwood JE, Lockett SL, Iwata A, Winn RK, Roth MB: Surviving blood loss using hydrogen sulfide. J Trauma. 2008, 65: 183-188. 10.1097/TA.0b013e3181507579.CrossRefPubMed Morrison ML, Blackwood JE, Lockett SL, Iwata A, Winn RK, Roth MB: Surviving blood loss using hydrogen sulfide. J Trauma. 2008, 65: 183-188. 10.1097/TA.0b013e3181507579.CrossRefPubMed
17.
go back to reference Mok YY, Atan MS, Yoke PC, Zhong JW, Bhatia M, Moochhala S, Moore PK: Role of hydrogen sulphide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis. Br J Pharmacol. 2004, 143: 881-889. 10.1038/sj.bjp.0706014.PubMedCentralCrossRefPubMed Mok YY, Atan MS, Yoke PC, Zhong JW, Bhatia M, Moochhala S, Moore PK: Role of hydrogen sulphide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis. Br J Pharmacol. 2004, 143: 881-889. 10.1038/sj.bjp.0706014.PubMedCentralCrossRefPubMed
18.
go back to reference Wiggers C: Present status of shock problem. Physiol Rev. 1942, 22: 74-123. Wiggers C: Present status of shock problem. Physiol Rev. 1942, 22: 74-123.
19.
go back to reference Meziani F, Kremer H, Tesse A, Baron-Menguy C, Mathien C, Mostefai HA, Carusio N, Schneider F, Asfar P, Andriantsitohaina R: Human serum albumin improves arterial dysfunction during early resuscitation in mouse endotoxic model via reduced oxidative and nitrosative stresses. Am J Pathol. 2007, 171: 1753-1761. 10.2353/ajpath.2007.070316.PubMedCentralCrossRefPubMed Meziani F, Kremer H, Tesse A, Baron-Menguy C, Mathien C, Mostefai HA, Carusio N, Schneider F, Asfar P, Andriantsitohaina R: Human serum albumin improves arterial dysfunction during early resuscitation in mouse endotoxic model via reduced oxidative and nitrosative stresses. Am J Pathol. 2007, 171: 1753-1761. 10.2353/ajpath.2007.070316.PubMedCentralCrossRefPubMed
20.
go back to reference Dombkowski RA, Russell MJ, Schulman AA, Doellman MM, Olson KR: Vertebrate phylogeny of hydrogen sulfide vasoactivity. Am J Physiol Regul Integr Comp Physiol. 2005, 288: R243-R252.CrossRefPubMed Dombkowski RA, Russell MJ, Schulman AA, Doellman MM, Olson KR: Vertebrate phylogeny of hydrogen sulfide vasoactivity. Am J Physiol Regul Integr Comp Physiol. 2005, 288: R243-R252.CrossRefPubMed
21.
go back to reference Koenitzer JR, Isbell TS, Patel HD, Benavides GA, Dickinson DA, Patel RP, Darley-Usmar VM, Lancaster JR, Doeller JE, Kraus DW: Hydrogen sulfide mediates vasoactivity in an O2-dependent manner. Am J Physiol Heart Circ Physiol. 2007, 292: H1953-H1960. 10.1152/ajpheart.01193.2006.CrossRefPubMed Koenitzer JR, Isbell TS, Patel HD, Benavides GA, Dickinson DA, Patel RP, Darley-Usmar VM, Lancaster JR, Doeller JE, Kraus DW: Hydrogen sulfide mediates vasoactivity in an O2-dependent manner. Am J Physiol Heart Circ Physiol. 2007, 292: H1953-H1960. 10.1152/ajpheart.01193.2006.CrossRefPubMed
22.
go back to reference Simon F, Giudici R, Duy CN, Schelzig H, Oter S, Groger M, Wachter U, Vogt J, Speit G, Szabo C, Radermacher P, Calzia E: Hemodynamic and metabolic effects of hydrogen sulfide during porcine ischemia/reperfusion injury. Shock. 2008, 30: 359-364. 10.1097/SHK.0b013e3181674185.CrossRefPubMed Simon F, Giudici R, Duy CN, Schelzig H, Oter S, Groger M, Wachter U, Vogt J, Speit G, Szabo C, Radermacher P, Calzia E: Hemodynamic and metabolic effects of hydrogen sulfide during porcine ischemia/reperfusion injury. Shock. 2008, 30: 359-364. 10.1097/SHK.0b013e3181674185.CrossRefPubMed
23.
go back to reference Volpato GP, Searles R, Yu B, Scherrer-Crosbie M, Bloch KD, Ichinose F, Zapol WM: Inhaled hydrogen sulfide: a rapidly reversible inhibitor of cardiac and metabolic function in the mouse. Anesthesiology. 2008, 108: 659-668. 10.1097/ALN.0b013e318167af0d.PubMedCentralCrossRefPubMed Volpato GP, Searles R, Yu B, Scherrer-Crosbie M, Bloch KD, Ichinose F, Zapol WM: Inhaled hydrogen sulfide: a rapidly reversible inhibitor of cardiac and metabolic function in the mouse. Anesthesiology. 2008, 108: 659-668. 10.1097/ALN.0b013e318167af0d.PubMedCentralCrossRefPubMed
24.
go back to reference Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L, Jiao X, Scalia R, Kiss L, Szabo C, Kimura H, Chow CW, Lefer DJ: Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA. 2007, 104: 15560-15565. 10.1073/pnas.0705891104.PubMedCentralCrossRefPubMed Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L, Jiao X, Scalia R, Kiss L, Szabo C, Kimura H, Chow CW, Lefer DJ: Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA. 2007, 104: 15560-15565. 10.1073/pnas.0705891104.PubMedCentralCrossRefPubMed
25.
go back to reference Oh GS, Pae HO, Lee BS, Kim BN, Kim JM, Kim HR, Jeon SB, Jeon WK, Chae HJ, Chung HT: Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kappaB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide. Free Radic Biol Med. 2006, 41: 106-119. 10.1016/j.freeradbiomed.2006.03.021.CrossRefPubMed Oh GS, Pae HO, Lee BS, Kim BN, Kim JM, Kim HR, Jeon SB, Jeon WK, Chae HJ, Chung HT: Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kappaB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide. Free Radic Biol Med. 2006, 41: 106-119. 10.1016/j.freeradbiomed.2006.03.021.CrossRefPubMed
26.
go back to reference Zanardo RC, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, Wallace JL: Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J. 2006, 20: 2118-2120. 10.1096/fj.06-6270fje.CrossRefPubMed Zanardo RC, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, Wallace JL: Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J. 2006, 20: 2118-2120. 10.1096/fj.06-6270fje.CrossRefPubMed
27.
go back to reference Kubo S, Doe I, Kurokawa Y, Nishikawa H, Kawabata A: Direct inhibition of endothelial nitric oxide synthase by hydrogen sulfide: contribution to dual modulation of vascular tension. Toxicology. 2007, 232: 138-146. 10.1016/j.tox.2006.12.023.CrossRefPubMed Kubo S, Doe I, Kurokawa Y, Nishikawa H, Kawabata A: Direct inhibition of endothelial nitric oxide synthase by hydrogen sulfide: contribution to dual modulation of vascular tension. Toxicology. 2007, 232: 138-146. 10.1016/j.tox.2006.12.023.CrossRefPubMed
28.
go back to reference Jeong SO, Pae HO, Oh GS, Jeong GS, Lee BS, Lee S, Kim DY, Rhew HY, Lee KM, Chung HT: Hydrogen sulfide potentiates interleukin-1β-induced nitric oxide production via enhancement of extracellular signal-regulated kinase activation in rat vascular smooth muscle cells. Biochem Biophys Res Commun. 2006, 345: 938-944. 10.1016/j.bbrc.2006.05.002.CrossRefPubMed Jeong SO, Pae HO, Oh GS, Jeong GS, Lee BS, Lee S, Kim DY, Rhew HY, Lee KM, Chung HT: Hydrogen sulfide potentiates interleukin-1β-induced nitric oxide production via enhancement of extracellular signal-regulated kinase activation in rat vascular smooth muscle cells. Biochem Biophys Res Commun. 2006, 345: 938-944. 10.1016/j.bbrc.2006.05.002.CrossRefPubMed
29.
go back to reference Li L, Whiteman M, Guan YY, Neo KL, Cheng Y, Lee SW, Zhao Y, Baskar R, Tan CH, Moore PK: Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide. Circulation. 2008, 117: 2351-2360. 10.1161/CIRCULATIONAHA.107.753467.CrossRefPubMed Li L, Whiteman M, Guan YY, Neo KL, Cheng Y, Lee SW, Zhao Y, Baskar R, Tan CH, Moore PK: Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide. Circulation. 2008, 117: 2351-2360. 10.1161/CIRCULATIONAHA.107.753467.CrossRefPubMed
30.
go back to reference Esechie A, Kiss L, Olah G, Horvath EM, Hawkins H, Szabo C, Traber DL: Protective effect of hydrogen sulfide in a murine model of acute lung injury induced by combined burn and smoke inhalation. Clin Sci (Lond). 2008, 115: 91-97. 10.1042/CS20080021.CrossRef Esechie A, Kiss L, Olah G, Horvath EM, Hawkins H, Szabo C, Traber DL: Protective effect of hydrogen sulfide in a murine model of acute lung injury induced by combined burn and smoke inhalation. Clin Sci (Lond). 2008, 115: 91-97. 10.1042/CS20080021.CrossRef
31.
go back to reference Maines MD, Mayer RD, Ewing JF, McCoubrey WK: Induction of kidney heme oxygenase-1 (HSP32) mRNA and protein by ischemia/reperfusion: possible role of heme as both promotor of tissue damage and regulator of HSP32. J Pharmacol Exp Ther. 1993, 264: 457-462.PubMed Maines MD, Mayer RD, Ewing JF, McCoubrey WK: Induction of kidney heme oxygenase-1 (HSP32) mRNA and protein by ischemia/reperfusion: possible role of heme as both promotor of tissue damage and regulator of HSP32. J Pharmacol Exp Ther. 1993, 264: 457-462.PubMed
32.
go back to reference Scarpulla RC: Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev. 2008, 88: 611-638. 10.1152/physrev.00025.2007.CrossRefPubMed Scarpulla RC: Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev. 2008, 88: 611-638. 10.1152/physrev.00025.2007.CrossRefPubMed
33.
go back to reference Wagener FA, Volk HD, Willis D, Abraham NG, Soares MP, Adema GJ, Figdor CG: Different faces of the heme-heme oxygenase system in inflammation. Pharmacol Rev. 2003, 55: 551-571. 10.1124/pr.55.3.5.CrossRefPubMed Wagener FA, Volk HD, Willis D, Abraham NG, Soares MP, Adema GJ, Figdor CG: Different faces of the heme-heme oxygenase system in inflammation. Pharmacol Rev. 2003, 55: 551-571. 10.1124/pr.55.3.5.CrossRefPubMed
34.
go back to reference Sivarajah A, Collino M, Yasin M, Benetti E, Gallicchio M, Mazzon E, Cuzzocrea S, Fantozzi R, Thiemermann C: Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I/R. Shock. 2009, 31: 267-274. 10.1097/SHK.0b013e318180ff89.CrossRefPubMed Sivarajah A, Collino M, Yasin M, Benetti E, Gallicchio M, Mazzon E, Cuzzocrea S, Fantozzi R, Thiemermann C: Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I/R. Shock. 2009, 31: 267-274. 10.1097/SHK.0b013e318180ff89.CrossRefPubMed
35.
go back to reference Huang HC, Nguyen T, Pickett CB: Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J Biol Chem. 2002, 277: 42769-42774. 10.1074/jbc.M206911200.CrossRefPubMed Huang HC, Nguyen T, Pickett CB: Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J Biol Chem. 2002, 277: 42769-42774. 10.1074/jbc.M206911200.CrossRefPubMed
36.
go back to reference Tamion F, Richard V, Bonmarchand G, Leroy J, Lebreton JP, Thuillez C: Induction of heme-oxygenase-1 prevents the systemic responses to hemorrhagic shock. Am J Respir Crit Care Med. 2001, 164: 1933-1938.CrossRefPubMed Tamion F, Richard V, Bonmarchand G, Leroy J, Lebreton JP, Thuillez C: Induction of heme-oxygenase-1 prevents the systemic responses to hemorrhagic shock. Am J Respir Crit Care Med. 2001, 164: 1933-1938.CrossRefPubMed
37.
go back to reference Tripatara P, Sa PN, Collino M, Gallicchio M, Kieswich J, Castiglia S, Benetti E, Stewart KN, Brown PA, Yaqoob MM, Fantozzi R, Thiemermann C: Generation of endogenous hydrogen sulfide by cystathionine-γ-lyase limits renal ischemia/reperfusion injury and dysfunction. Lab Invest. 2008, 88: 1038-1048. 10.1038/labinvest.2008.73.CrossRefPubMed Tripatara P, Sa PN, Collino M, Gallicchio M, Kieswich J, Castiglia S, Benetti E, Stewart KN, Brown PA, Yaqoob MM, Fantozzi R, Thiemermann C: Generation of endogenous hydrogen sulfide by cystathionine-γ-lyase limits renal ischemia/reperfusion injury and dysfunction. Lab Invest. 2008, 88: 1038-1048. 10.1038/labinvest.2008.73.CrossRefPubMed
38.
go back to reference Patel NS, Brancaleone V, Renshaw D, Rocha J, Sepodes B, Mota-Filipe H, Perretti M, Thiemermann C: Characterisation of cystathionine gamma-lyase/hydrogen sulphide pathway in ischaemia/reperfusion injury of the mouse kidney: an in vivo study. Eur J Pharmacol. 2009, 606: 205-209. 10.1016/j.ejphar.2009.01.041.CrossRefPubMed Patel NS, Brancaleone V, Renshaw D, Rocha J, Sepodes B, Mota-Filipe H, Perretti M, Thiemermann C: Characterisation of cystathionine gamma-lyase/hydrogen sulphide pathway in ischaemia/reperfusion injury of the mouse kidney: an in vivo study. Eur J Pharmacol. 2009, 606: 205-209. 10.1016/j.ejphar.2009.01.041.CrossRefPubMed
39.
go back to reference Sivarajah A, McDonald MC, Thiemermann C: The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat. Shock. 2006, 26: 154-161. 10.1097/01.shk.0000225722.56681.64.CrossRefPubMed Sivarajah A, McDonald MC, Thiemermann C: The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat. Shock. 2006, 26: 154-161. 10.1097/01.shk.0000225722.56681.64.CrossRefPubMed
40.
go back to reference Jha S, Calvert JW, Duranski MR, Ramachandran A, Lefer DJ: Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signaling. Am J Physiol Heart Circ Physiol. 2008, 295: H801-H806. 10.1152/ajpheart.00377.2008.PubMedCentralCrossRefPubMed Jha S, Calvert JW, Duranski MR, Ramachandran A, Lefer DJ: Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signaling. Am J Physiol Heart Circ Physiol. 2008, 295: H801-H806. 10.1152/ajpheart.00377.2008.PubMedCentralCrossRefPubMed
41.
go back to reference Sodha NR, Clements RT, Feng J, Liu Y, Bianchi C, Horvath EM, Szabó C, Sellke FW: The effects of therapeutic sulfide on myocardial apoptosis in response to ischemia-reperfusion injury. Eur J Cardiothorac Surg. 2008, 33: 906-913. 10.1016/j.ejcts.2008.01.047.PubMedCentralCrossRefPubMed Sodha NR, Clements RT, Feng J, Liu Y, Bianchi C, Horvath EM, Szabó C, Sellke FW: The effects of therapeutic sulfide on myocardial apoptosis in response to ischemia-reperfusion injury. Eur J Cardiothorac Surg. 2008, 33: 906-913. 10.1016/j.ejcts.2008.01.047.PubMedCentralCrossRefPubMed
Metadata
Title
Effects of hydrogen sulfide on hemodynamics, inflammatory response and oxidative stress during resuscitated hemorrhagic shock in rats
Authors
Frédérique Ganster
Mélanie Burban
Mathilde de la Bourdonnaye
Lionel Fizanne
Olivier Douay
Laurent Loufrani
Alain Mercat
Paul Calès
Peter Radermacher
Daniel Henrion
Pierre Asfar
Ferhat Meziani
Publication date
01-10-2010
Publisher
BioMed Central
Published in
Critical Care / Issue 5/2010
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc9257

Other articles of this Issue 5/2010

Critical Care 5/2010 Go to the issue